Eernisse JG - Search Results

1

Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.

Claas FH, Smeenk RJ, Schmidt R, van Steenbrugge GJ, Eernisse JG. Claas FH, et al. Among authors: eernisse jg. Exp Hematol. 1981 Jan;9(1):84-9. Exp Hematol. 1981. PMID: 7238645

2

Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions.

Brand A, Claas FH, Voogt PJ, Wasser MN, Eernisse JG. Brand A, et al. Among authors: eernisse jg. Vox Sang. 1988;54(3):160-6. doi: 10.1111/j.1423-0410.1988.tb03892.x. Vox Sang. 1988. PMID: 3369136

3

Blood component therapy in bone marrow transplantation.

Brand A, Claas FH, Falkenburg JH, van Rood JJ, Eernisse JG. Brand A, et al. Among authors: eernisse jg. Semin Hematol. 1984 Apr;21(2):141-55. Semin Hematol. 1984. PMID: 6330905 Review. No abstract available.

4

ABH antibodies causing platelet transfusion refractoriness.

Brand A, Sintnicolaas K, Claas FH, Eernisse JG. Brand A, et al. Among authors: eernisse jg. Transfusion. 1986 Sep-Oct;26(5):463-6. doi: 10.1046/j.1537-2995.1986.26587020127.x. Transfusion. 1986. PMID: 3532447

5

Beneficial effect of intravenous gammaglobulin in a patient with complement-mediated autoimmune thrombocytopenia due to IgM-anti-platelet antibodies.

Brand A, Witvliet M, Claas FH, Eernisse JG. Brand A, et al. Among authors: eernisse jg. Br J Haematol. 1988 Aug;69(4):507-11. doi: 10.1111/j.1365-2141.1988.tb02407.x. Br J Haematol. 1988. PMID: 3408686

6

Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.

Eernisse JG, Brand A. Eernisse JG, et al. Exp Hematol. 1981 Jan;9(1):77-83. Exp Hematol. 1981. PMID: 7238644

7

Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.

Brand A, van Leeuwen A, Eernisse JG, van Rood JJ. Brand A, et al. Among authors: eernisse jg. Blood. 1978 May;51(5):781-8. Blood. 1978. PMID: 346088 Free article.

8

Removal of red cells in ABO-incompatible bone marrow transplantation.

Schaafsma MR, Falkenburg JH, Eernisse JG. Schaafsma MR, et al. Among authors: eernisse jg. Lancet. 1983 Jan 1;1(8314-5):67. doi: 10.1016/s0140-6736(83)91598-2. Lancet. 1983. PMID: 6129396 No abstract available.

9

Successful bone marrow transplantation for aplastic anemia using a HLA phenotypically identical parent.

Tricot GJ, Jansen J, Zwaan FE, Eernisse JG, Sabre L, van Rood JJ. Tricot GJ, et al. Among authors: eernisse jg. Transplantation. 1981 Jan;31(1):86-7. doi: 10.1097/00007890-198101000-00019. Transplantation. 1981. PMID: 7015606 No abstract available.

10

Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti-thymocyte globulin.

de Planque MM, Brand A, Kluin-Nelemans HC, Eernisse JG, van der Burgh F, Natarajan AT, Beverstock GC, Zwaan FE, Willemze R, van Rood JJ. de Planque MM, et al. Among authors: eernisse jg. Br J Haematol. 1989 Mar;71(3):421-30. doi: 10.1111/j.1365-2141.1989.tb04301.x. Br J Haematol. 1989. PMID: 2784688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page